Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN J CALLAGHAN

Allopathic & Osteopathic Physicians Orthopaedic Surgery

NPI
1154316636
CMS profile
1221685
Location
IOWA CITY, IA

General Payments · PY2018–2024

$24,465,891.05

  • Reported across 247 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,213,662.69

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Royalty or License $2,213,478.42 10
Food and Beverage $184.27 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
DePuy Synthes Products LLC $2,213,478.42 10
Medical Device Business Services, Inc. $184.27 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,142,558.51 58
PY2019 $5,034,601.21 77
PY2020 $4,069,197.46 29
PY2021 $3,899,684.56 27
PY2022 $2,422,552.90 16
PY2023 $2,683,633.72 28
PY2024 $2,213,662.69 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
DePuy Synthes Products, Inc. $208,300.59 02/26/2024 Royalty or License Undisputed 01/23/2026 1077794889 CMS
DePuy Synthes Products, Inc. $32,338.90 03/15/2024 Royalty or License Undisputed 01/23/2026 1077794901 CMS
DePuy Synthes Products, Inc. $1,691.92 03/15/2024 Royalty or License Undisputed 01/23/2026 1077796683 CMS
DePuy Synthes Products, Inc. $479,332.58 05/31/2024 Royalty or License Undisputed 01/23/2026 1077794905 CMS
DePuy Synthes Products, Inc. $38,799.75 06/26/2024 Royalty or License Undisputed 01/23/2026 1077794897 CMS
DePuy Synthes Products, Inc. $48,741.42 06/26/2024 Royalty or License Undisputed 01/23/2026 1077796679 CMS
DePuy Synthes Products, Inc. $883,305.01 08/26/2024 Royalty or License Undisputed 01/23/2026 1077794893 CMS
DePuy Synthes Products, Inc. $39,326.36 09/25/2024 Royalty or License Undisputed 01/23/2026 1077794885 CMS
DePuy Synthes Products, Inc. $42,335.05 09/25/2024 Royalty or License Undisputed 01/23/2026 1077796686 CMS
DePuy Synthes Products, Inc. $439,306.84 11/25/2024 Royalty or License Undisputed 01/23/2026 1077794882 CMS
Medical Device Business Services, Inc. $154.83 02/13/2024 Food and Beverage Undisputed 01/23/2026 1077780341 CMS
Medical Device Business Services, Inc. $29.44 02/17/2024 Food and Beverage Undisputed 01/23/2026 1077780213 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.